Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Study underestimated morbidity due to specific pathogens
| The first 150 words of the full text of this article appear below. |
EDITOR
Wheeler et al's paper estimates the burden of symptomatic
infectious intestinal disease in the United Kingdom.1 One
aspect of their findings was the high proportion (55%) of community
episodes in which no pathogen was identified. I would suggest that this
study severely underestimates the prevalence of certain intestinal
pathogens. For example, the authors calculate the incidence of
cryptosporidium infection in their community study to be only 0.81 (95% confidence interval 0.26 to 2.5) per 1000 person years.
Another approach to determining the incidence of an infectious disease is to determine the prevalence of antibodies in the community and then calculate the annual attack rate required to give that degree of antibody positivity. If an individual is assumed to remain antibody positive for life after an infection then this attack rate is given by a simple formula: cases/100 person years=% seropositive/average life expectancy.
Few studies of cryptosporidium antibodies have been carried out